{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:26:07Z","timestamp":1790533567041,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurol.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T04:18:04Z","timestamp":1478751484000},"page":"761-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Parkinson's disease and solvents: Is there a causal link?"],"prefix":"10.1016","volume":"172","author":[{"given":"J.","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Benbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bonneterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2016.09.012_bib0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neurol.2010.07.008","article-title":"Parkinson's disease: is there a strong environmental contribution?","volume":"166","author":"Elbaz","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuro.2012.01.010","article-title":"Industrial toxicants and Parkinson's disease","volume":"33","author":"Caudle","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2016.09.012_bib0190","first-page":"53","article-title":"Organic solvent neurotoxicity facts and research needs","volume":"11","author":"Spencer","year":"1985","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.neurol.2016.09.012_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/oem.2005.022400","article-title":"Solvent neurotoxicity","volume":"63","author":"Dick","year":"2006","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.neurol.2016.09.012_bib0200","unstructured":"Millar JD. Organic solvent neurotoxicity DHHS (NIOSH) Publication Number 87-104. Current Intelligence June 6, 2014. Bulletin 48. www.cdc.gov\/niosh\/docs\/87-104\/."},{"key":"10.1016\/j.neurol.2016.09.012_bib0205","series-title":"Experimental and clinical neurotoxicology","first-page":"456","article-title":"n-Hexane and methyl n-butyl ketone","author":"Spencer","year":"1980"},{"key":"10.1016\/j.neurol.2016.09.012_bib0210","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.neuro.2009.06.002","article-title":"The course of chronic solvent induced encephalopathy: a systematic review","volume":"30","author":"Van Valen","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0215","first-page":"196","article-title":"Parosmia and hyposmia induced by solvent exposure","volume":"33","author":"Emmett","year":"1976","journal-title":"Br J Indust Med"},{"key":"10.1016\/j.neurol.2016.09.012_bib0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.smrv.2008.07.003","article-title":"Sleep disturbances and occupational exposure to solvents","volume":"13","author":"Viaene","year":"2009","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neurol.2016.09.012_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0042961","article-title":"Long-term occupational exposures to organic solvents affects color vision, contrast sensitivity and visual fields","volume":"7","author":"Costa","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.neurol.2016.09.012_bib0230","first-page":"265","article-title":"Solvent-induced hearing loss: mechanisms and prevention strategy","volume":"20","author":"Campo","year":"2006","journal-title":"Int J Occup Med Environ Health"},{"key":"10.1016\/j.neurol.2016.09.012_bib0235","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.108.059998","article-title":"Imaging approaches to Parkinson disease","volume":"51","author":"Brooks","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurol.2016.09.012_bib0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/enrs.1997.3701","article-title":"An international questionnaire to explore neurotoxic symptoms","volume":"73","author":"Chouani\u00e8re","year":"1997","journal-title":"Environ Res"},{"key":"10.1016\/j.neurol.2016.09.012_bib0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0161-813X(03)00075-5","article-title":"Evaluation of the French version of EUROQUEST: a questionnaire for neurotoxic symptoms","volume":"24","author":"Rouch","year":"2003","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0250","series-title":"Etiology of Parkinson's disease","first-page":"319","article-title":"Environmental agents and Parkinson's disease","author":"Spencer","year":"1995"},{"issue":"1","key":"10.1016\/j.neurol.2016.09.012_bib0255","first-page":"3","article-title":"Carbon disulfide neurotoxicity: Taiwan experience","volume":"13","author":"Huang","year":"2004","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.neurol.2016.09.012_bib0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.21288","article-title":"Trichloroethylene: Parkinsonism and complex\u00a01 mitochondrial neurotoxicity","volume":"63","author":"Gash","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0265","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1468-1331.1999.650609.x","article-title":"Trichloroethylene and parkinsonism: a human and experimental observation","volume":"6","author":"Guehl","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0270","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4615-0135-0_29","article-title":"The endogenous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease","volume":"527","author":"Kochen","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(89)93050-X","article-title":"Parkinsonism due to n-hexane exposure","volume":"2","author":"Pezzoli","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2016.09.012_bib0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.870100308","article-title":"n-Hexane-induced Parkinsonism: pathogenetic hypotheses","volume":"10","author":"Pezzoli","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2016.09.012_bib0285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s004150050334","article-title":"Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure","volume":"246","author":"Hageman","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0161-813X(03)00147-5","article-title":"Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism","volume":"25","author":"Huang","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0295","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5271\/sjweh.2549","article-title":"Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury-a case-referent study","volume":"7","author":"Ohlson","year":"1981","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.neurol.2016.09.012_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-11-83","article-title":"Occupational risk factors for Parkinson's disease: a case-control study in Japan","volume":"11","author":"Tanaka","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0305","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2012.11.016","article-title":"Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence","volume":"266","author":"Lock","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0310","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1586\/ern.10.61","article-title":"Trichloroethylene and Parkinson's disease: dissolving the puzzle","volume":"10","author":"Goldman","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neurol.2016.09.012_bib0315","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.22629","article-title":"Solvent exposures and Parkinson disease risk in twins","volume":"71","author":"Goldman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.09.012_bib0320","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","article-title":"Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344\u00a0rats","volume":"112","author":"Liu","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2016.09.012_bib0325","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1212\/WNL.55.5.667","article-title":"Hydrocarbon exposure and Parkinson's disease","volume":"55","author":"Pezzoli","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0330","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"Pezzoli","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.09.012_bib0335","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/oemed-2014-102209","article-title":"Occupational exposures and Parkinson's disease mortality in a prospective Dutch cohort","volume":"72","author":"Brouwer","year":"2015","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.neurol.2016.09.012_bib0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/oem.2005.024067","article-title":"Occupational exposure to organic solvent mixtures during pregnancy and the risk of non-syndromic oral clefts","volume":"63","author":"Chevrier","year":"2006","journal-title":"Occup Environ Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716300777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T21:51:04Z","timestamp":1536270664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716300777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0035378716300777"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.09.012","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease and solvents: Is there a causal link?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}